Daclizumab (trade name Zinbryta, by Biogen) is a therapeutic humanized monoclonal antibody which was used for the treatment of adults with relapsing forms of multiple sclerosis (MS). Le daclizumab (nom commercial Zinbryta) est un anticorps monoclonal humanisé (chimère homme-souris) utilisé pour le traitement des adultes atteints de formes récidivantes de sclérose en plaques.
